表紙
市場調查報告書
商品編碼
1056501

血糖監測系統的全球市場:各類型,各用途,各終端用戶,不同地區的預測(到2027年) - COVID-19累積的影響

Glucose Monitoring Devices Market Research Report by Type, by Application, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球血糖監測系統的市場規模在2020年估算為52億9,178萬美金,2021年為59億86萬美元,此後預計將以11.94%的年複合成長率推移,到2027年前達到116億5,660萬美元。

本報告提供全球血糖監測系統市場的相關調查,提供市場機會和課題,促進及阻礙因素,COVID-19累積的影響,各類型·各用途·各終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 前提條件
  • 利害關係者

第2章 調查手法

  • 定義:調查目的
  • 決策:調查計劃
  • 準備:調查設備
  • 收集:資料來源
  • 分析:資料的解釋
  • 制定:資料檢驗
  • 公開:調查報告
  • 重複:報告的更新

第3章 摘要整理

第4章 市場概要

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19累積的影響

第6章 血糖監測系統市場:各類型

  • 糖尿病監測設備
    • 持續血糖監測系統
    • 血糖計
    • 血糖測試紙
    • 採血針·穿刺器具
  • 胰島素輸送(給藥)設備
    • 胰島素筆針
    • 胰島素幫浦
    • 胰島素注射器

第7章 血糖監測系統市場:各用途

  • 妊娠糖尿病
  • 第一型糖尿病
  • 第二型糖尿病

第8章 血糖監測系統市場:各終端用戶

  • 診斷
  • 家庭舞台裝置
  • 醫院

第9章 南北美洲的血糖監測系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區的血糖監測系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國

第11章 歐洲,中東·非洲的血糖監測系統市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析:各主要企業
  • 競爭模式
    • 合併·收購
    • 協定,合作,及的夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第13章 企業的實用性簡介

  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Bayer HealthCare AG
  • Becton
  • DexCom, Inc.
  • Dickinson & Company
  • GE Healthcare
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Johnson & Johnson
  • Lupin Limited
  • Medtronic, Inc.
  • Merck & Co., Inc.
  • Nova Biomedical Corporation
  • Novartis International AG
  • Omron Healthcare
  • Philips Healthcare
  • ResMed Inc.
  • Roche
  • Senseonics
  • Takeda Pharmaceutical Company Limited

第14章 附錄

  • 討論指南
目錄
Product Code: MRR-436B79517C61

The Global Glucose Monitoring Devices Market size was estimated at USD 5,291.78 million in 2020 and expected to reach USD 5,900.86 million in 2021, at a CAGR 11.94% to reach USD 11,656.60 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Glucose Monitoring Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Diabetes Monitoring Devices and Insulin Delivery Devices. The Diabetes Monitoring Devices is further studied across Continuous Glucose Monitoring Devices, Glucose Meter, Glucose Test Strips, and Lancets and Lancing Devices. The Insulin Delivery Devices is further studied across Insulin Pens, Insulin Pumps, and Insulin Syringes.

Based on Application, the market was studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.

Based on End User , the market was studied across Diagnostics, Home Settings, and Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Glucose Monitoring Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Glucose Monitoring Devices Market, including AstraZeneca plc, B. Braun Melsungen AG, Bayer HealthCare AG, Becton, DexCom, Inc., Dickinson & Company, GE Healthcare, GlaxoSmithKline plc, Insulet Corporation, Johnson & Johnson, Lupin Limited, Medtronic, Inc., Merck & Co., Inc., Nova Biomedical Corporation, Novartis International AG, Omron Healthcare, Philips Healthcare, ResMed Inc., Roche, Senseonics, and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Glucose Monitoring Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Glucose Monitoring Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Glucose Monitoring Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Glucose Monitoring Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Glucose Monitoring Devices Market?
  • 6. What is the market share of the leading vendors in the Global Glucose Monitoring Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Glucose Monitoring Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Chronic illness including blood pressure, diabetes asthma and cardiovascular diseases require regular and continuous monitoring for a lifetime
      • 5.1.1.2. Constant improvements in the self-monitoring blood glucose (SMBG) devices and point of caring testing (POCT) devices
      • 5.1.1.3. Increasing demand for home-based treatment and self-medication to manage irregular chronic and acute illnesses
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavourable reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and excessive research & development
      • 5.1.3.2. Poor dietary habits, sedentary lifestyle, and development of new technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization
  • 5.2. Cumulative Impact of COVID-19

6. Glucose Monitoring Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Diabetes Monitoring Devices
    • 6.2.1. Continuous Glucose Monitoring Devices
    • 6.2.2. Glucose Meter
    • 6.2.3. Glucose Test Strips
    • 6.2.4. Lancets and Lancing Devices
  • 6.3. Insulin Delivery Devices
    • 6.3.1. Insulin Pens
    • 6.3.2. Insulin Pumps
    • 6.3.3. Insulin Syringes

7. Glucose Monitoring Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Gestational Diabetes
  • 7.3. Type 1 Diabetes
  • 7.4. Type 2 Diabetes

8. Glucose Monitoring Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Home Settings
  • 8.4. Hospitals

9. Americas Glucose Monitoring Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glucose Monitoring Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Glucose Monitoring Devices Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AstraZeneca plc
  • 13.2. B. Braun Melsungen AG
  • 13.3. Bayer HealthCare AG
  • 13.4. Becton
  • 13.5. DexCom, Inc.
  • 13.6. Dickinson & Company
  • 13.7. GE Healthcare
  • 13.8. GlaxoSmithKline plc
  • 13.9. Insulet Corporation
  • 13.10. Johnson & Johnson
  • 13.11. Lupin Limited
  • 13.12. Medtronic, Inc.
  • 13.13. Merck & Co., Inc.
  • 13.14. Nova Biomedical Corporation
  • 13.15. Novartis International AG
  • 13.16. Omron Healthcare
  • 13.17. Philips Healthcare
  • 13.18. ResMed Inc.
  • 13.19. Roche
  • 13.20. Senseonics
  • 13.21. Takeda Pharmaceutical Company Limited

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
  • FIGURE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2027
  • FIGURE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2027 (USD MILLION)
  • FIGURE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2027 (USD MILLION)
  • FIGURE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, 2018-2027 (USD MILLION)
  • FIGURE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, 2018-2027 (USD MILLION)
  • FIGURE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, 2018-2027 (USD MILLION)
  • FIGURE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2027 (USD MILLION)
  • FIGURE 17. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 18. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2027 (USD MILLION)
  • FIGURE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 20. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2027 (USD MILLION)
  • FIGURE 21. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 22. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, 2018-2027 (USD MILLION)
  • FIGURE 23. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 24. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
  • FIGURE 25. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 27. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, 2018-2027 (USD MILLION)
  • FIGURE 28. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 29. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, 2018-2027 (USD MILLION)
  • FIGURE 30. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 31. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, 2018-2027 (USD MILLION)
  • FIGURE 32. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 33. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER , 2020 VS 2027 (%)
  • FIGURE 34. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER , 2020 VS 2027 (USD MILLION)
  • FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER , 2027
  • FIGURE 36. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2027 (USD MILLION)
  • FIGURE 37. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 38. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, 2018-2027 (USD MILLION)
  • FIGURE 39. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 40. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
  • FIGURE 41. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 42. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 43. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 44. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 45. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 46. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 47. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 48. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 49. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 50. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 51. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 52. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 53. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 54. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 55. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 56. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 57. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 58. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 59. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 61. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 62. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 63. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 64. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 65. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 66. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 67. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 68. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 69. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 70. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 71. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 72. GLOBAL GLUCOSE MONITORING DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 73. GLOBAL GLUCOSE MONITORING DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GLUCOSE MONITORING DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER , 2018-2027 (USD MILLION)
  • TABLE 18. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 22. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 23. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 24. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 25. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 26. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 28. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 29. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 30. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 31. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 32. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 33. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 34. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 35. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 36. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 37. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 38. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 39. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 40. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 41. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 42. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 43. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 44. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 45. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 46. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 47. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 48. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 49. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 50. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 51. GLOBAL GLUCOSE MONITORING DEVICES MARKET: SCORES
  • TABLE 52. GLOBAL GLUCOSE MONITORING DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 53. GLOBAL GLUCOSE MONITORING DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 54. GLOBAL GLUCOSE MONITORING DEVICES MARKET: RANKING
  • TABLE 55. GLOBAL GLUCOSE MONITORING DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 56. GLOBAL GLUCOSE MONITORING DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 57. GLOBAL GLUCOSE MONITORING DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 58. GLOBAL GLUCOSE MONITORING DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 59. GLOBAL GLUCOSE MONITORING DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 60. GLOBAL GLUCOSE MONITORING DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 61. GLOBAL GLUCOSE MONITORING DEVICES MARKET: LICENSE & PRICING